Antibody against the CSF-1 R

Details for Australian Patent Application No. 2009224955 (hide)

Owner Transgene S.A.

Inventors Thioudellet, Christine; Grellier, Benoit; Haegel, Helene; Geist, Michel

Agent Freehills

Pub. Number AU-B-2009224955

PCT Pub. Number WO2009/112245

Priority 08360005.6 14.03.08 EP; 61/043.884 10.04.08 US

Filing date 11 March 2009

Wipo publication date 17 September 2009

Acceptance publication date 9 August 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 35/00 Antineoplastic agents

A61P 37/00 Drugs for immunological or allergic disorders

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

C12N 15/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/112245 Priority application(s): WO2009/112245

28 October 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 08 Sep 2010

9 August 2012 Application Accepted

  Published as AU-B-2009224955

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009224958-Method for the production of concrete pipes and concrete pipe system

2009224948-Method for adjusting the friction coefficient of a metallic workpiece